Intracisternal administration of interleukin-1 attenuates naloxone-precipitated withdrawal in morphine-dependent mice

By Katsumata S.   Minami M.   Nakagawa T.   Satoh M.  

European Journal of Pharmacology, Vol. 278, Iss. 2, 1995-05 ,pp. : 143-150

Elsevier

Access to resources Recommend Favorite

Dextromethorphan attenuates morphine withdrawal syndrome in neonatal rats passively exposed to morphine

By Yeh G.-C.   Tao P.-L.   Chen J.Y.-R.   Lai M.-C.   Gao F.-S.   Hu C.-L.  

European Journal of Pharmacology, Vol. 453, Iss. 2, 2002-10 ,pp. : 197-202

Elsevier

Access to resources Recommend Favorite

Modification of naloxone-induced withdrawal signs by dextromethorphan in morphine-dependent mice

By Farzin D.  

European Journal of Pharmacology, Vol. 377, Iss. 1, 1999-07 ,pp. : 35-42

Elsevier

Access to resources Recommend Favorite

The CRF₁ receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal

By Skelton Kelly   Gutman David   Thrivikraman K.   Nemeroff Charles   Owens Michael  

Psychopharmacology, Vol. 192, Iss. 3, 2007-06 ,pp. : 385-396

Springer Publishing Company

Access to resources Recommend Favorite

Repeated naltrexone administration accelerates resolution of morphine somatic withdrawal signs in morphine-dependent rats

By Muntoni A.L.   Diana M.   Gessa G.L.  

European Journal of Pharmacology, Vol. 301, Iss. 1, 1996-04 ,pp. : 9-10

Elsevier

Access to resources Recommend Favorite